0.7209
0.0029 (0.4%)
0.0029 (0.4%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| NovaBay Pharmaceuticals Inc New | NBY | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.0029 | 0.4% | 0.7209 | 12:08:28 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 0.72 | 0.74 | 0.721 | 0.718 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 359 | 147,603 | $ 0.7263275 | $ 107,208 | 3,161,656 | 0.20 - 2.18 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:07:25 | 28 | $ 0.7215 | USD |
NovaBay Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 30.09M | 41.74M | 31.22M | $ 6.60M | $ -6.40M | -0.53 | -4.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 515.08k | $ - | 0.00% | - | - |
NovaBay Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NBY Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.7881 | 0.80 | 0.69 | 0.7388675 | 451,112 | -0.0672 | -8.53% |
| 1 Month | 0.90 | 0.9372 | 0.67 | 0.7860116 | 923,773 | -0.1791 | -19.9% |
| 3 Months | 1.13 | 2.18 | 0.67 | 1.20 | 4,911,665 | -0.4091 | -36.2% |
| 6 Months | 0.8001 | 2.18 | 0.5382 | 1.12 | 4,626,583 | -0.0792 | -9.9% |
| 1 Year | 0.6497 | 2.18 | 0.20 | 1.10 | 2,915,829 | 0.0712 | 10.96% |
| 3 Years | 4.555 | 4.80 | 0.20 | 1.29 | 1,300,034 | -3.83 | -84.17% |
| 5 Years | 8.50 | 9.32 | 0.20 | 1.40 | 814,927 | -7.78 | -91.52% |
NovaBay Pharmaceuticals Description
| NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops, manufactures, and markets anti-infective products for a multitude of uses. It is predominantly focused on commercializing prescription Avenova for the domestic eye care market in the United States. Avenova is the only eye care product formulated with proprietary, stable and pure form of hypochlorous acid (marketed as Neutrox). The company develops additional products containing Neutrox, including its NeutroPhase Skin and Wound Cleanser for wound care and CelleRx for the dermatology market. It has partnerships for NeutroPhase in the United States, as well as in other markets. |
